Indian Clarity

Light. Truth. Clarity.

Loading ad...
AI

Park Medi World IPO vs Nephrocare Health IPO: What Does GMP Suggest On Day 1 Of IPO Launch

The initial public offerings (IPOs) for Park Medi World and Nephrocare Health Services opened for subscription on December 10, 2025. While Park Medi World is seeing a positive grey market premium indicating a potential listing gain, Nephrocare's IPO reflects a flat listing expectation. Both companies aim to raise significant capital, with Park Medi World targeting ₹920 crore and Nephrocare aiming for ₹871.05 crore.

Park Medi World IPO vs Nephrocare Health IPO: What Does GMP Suggest On Day 1 Of IPO Launch

Credit: Feedburner

Key Highlights

  • Park Medi World IPO aims to raise ₹920 crore with a price band of ₹154 to ₹162 per share.
  • Nephrocare Health Services IPO is priced between ₹438 and ₹460 per share, targeting ₹871.05 crore.
  • Park Medi World operates 14 multi-super speciality hospitals with a total capacity of 3,000 beds.
  • Nephrocare operates India's largest dialysis network across 288 cities and focuses on tier II and III regions.
  • Nephrocare IPO will be open until December 12, while Park Medi World will close on the same day.
Loading ad...

Sources

  1. Park Medi World IPO vs Nephrocare Health IPO: What Does GMP Suggest On Day 1 Of IPO Launch
  2. Nephrocare Health IPO Day 1 LIVE: Issue open for subscription; GMP flat - Apply or not?
  3. Nephrocare IPO Day 1: Issue booked 2% so far. Check GMP, review, issue details. Apply or not?
  4. Park Medi World IPO Day 1 LIVE: Issue opens today. GMP, subscription status, review, other key details. Apply or not?
  5. Park Medi World IPO Day 1: Check GMP, subscription status, review, and more - Should you apply?

This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.

Related Stories

Loading ad...